ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
7.02
-0.40 (-5.39%)
At close: Jun 12, 2025, 4:00 PM
7.02
0.00 (0.00%)
After-hours: Jun 12, 2025, 4:00 PM EDT
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 69 employees as of December 31, 2024. The number of employees increased by 8 or 13.11% compared to the previous year.
Employees
69
Change (1Y)
8
Growth (1Y)
13.11%
Revenue / Employee
$165,855
Profits / Employee
-$2,909,594
Market Cap
458.89M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ABVX News
- 1 day ago - Abivax Announces Results of its June 6, 2025 Annual General Meeting - GlobeNewsWire
- 10 days ago - Abivax Presents First Quarter 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis - GlobeNewsWire
- 7 weeks ago - Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones - GlobeNewsWire
- 7 weeks ago - Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors - GlobeNewsWire
- 2 months ago - Abivax publishes financial reports with the French and U.S. securities regulatory agencies - GlobeNewsWire
- 2 months ago - Abivax Announces Full Year 2024 Financial Results - GlobeNewsWire
- 3 months ago - Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025 - GlobeNewsWire